These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 20025967)

  • 1. Mechanism of hydrolysis of a novel indolocarbazole topoisomerase I inhibitor.
    Breslin D; Sato Y; Karki SB
    Eur J Pharm Sci; 2010 Mar; 39(5):291-7. PubMed ID: 20025967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral formulation and thermal degradation pathways of a potent rebeccamycin based indolocarbazole topoisomerase I inhibitor.
    Sato Y; Breslin D; Kitada H; Minagawa W; Nomoto T; Qin XZ; Karki SB
    Int J Pharm; 2010 May; 390(2):128-33. PubMed ID: 20074629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitors.
    Li Z; Zhai F; Zhao L; Guo Q; You Q
    Bioorg Med Chem Lett; 2009 Jan; 19(2):406-9. PubMed ID: 19058964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of ricobendazole in aqueous solutions.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
    Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J
    J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
    Roskar R; Simoncic Z; Gartner A; Kmetec V
    J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indolocarbazole glycosides in inactive conformations.
    Facompré M; Carrasco C; Vezin H; Chisholm JD; Yoburn JC; Van Vranken DL; Bailly C
    Chembiochem; 2003 May; 4(5):386-95. PubMed ID: 12740810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of barakol under hydrolytic stress conditions and its major degradation product.
    Chantong B; Wongtongtair S; Nusuetrong P; Sotanaphun U; Chaichantipyuth C; Meksuriyen D
    Planta Med; 2009 Mar; 75(4):346-50. PubMed ID: 19145556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and hydrolysis kinetics of spirosuccinimide type inhibitors of aldose reductase in aqueous solution and retardation of their hydrolysis by the target enzyme.
    Kurono M; Itogawa A; Noguchi H; Sanjoba M
    J Pharm Sci; 2008 Apr; 97(4):1468-83. PubMed ID: 17722083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
    Xiang TX; Niemi R; Bummer P; Anderson BD
    J Pharm Sci; 2003 Oct; 92(10):2027-39. PubMed ID: 14502542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation kinetics of butylmethoxydibenzoylmethane (avobenzone) in aqueous solution.
    Mbah CJ
    Pharmazie; 2007 Oct; 62(10):747-9. PubMed ID: 18236778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of new analgesic active compound, pyrrolo-[3,4-c]pyridine derivative, in aqueous solutions.
    Muszalska I; Wojtyniak E
    Acta Pol Pharm; 2007; 64(4):319-25. PubMed ID: 18536157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.
    Moreau P; Anizon F; Sancelme M; Prudhomme M; Bailly C; Carrasco C; Ollier M; Sevère D; Riou JF; Fabbro D; Meyer T; Aubertin AM
    J Med Chem; 1998 May; 41(10):1631-40. PubMed ID: 9572888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolytic products and kinetics of triazophos in buffered and alkaline solutions with different values of pH.
    Kunde L; Dongxing Y; Yongzhi D; Meng C
    J Agric Food Chem; 2004 Aug; 52(17):5404-11. PubMed ID: 15315377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic studies on the aminopeptidase from Aeromonas proteolytica: a two-metal ion mechanism for peptide hydrolysis.
    Chen G; Edwards T; D'souza VM; Holz RC
    Biochemistry; 1997 Apr; 36(14):4278-86. PubMed ID: 9100023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of 1,4,5,8-naphthalene tetracarboxylic acid dianhydride hydrolysis and formation in aqueous solution.
    Barros TC; Cuccovia IM; Farah JP; Masini JC; Chaimovich H; Politi MJ
    Org Biomol Chem; 2006 Jan; 4(1):71-82. PubMed ID: 16357999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability studies of hydralazine hydrochloride in aqueous solutions.
    Halasi S; Nairn JG
    J Parenter Sci Technol; 1990; 44(1):30-4. PubMed ID: 2313490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.
    Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T
    J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of the acid-catalyzed hydrolysis of acyclovir and an ester prodrug in aqueous solution.
    Jensen E; Bundgaard H
    Acta Pharm Nord; 1991; 3(3):147-50. PubMed ID: 1793509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.